1. Home
  2. HNI vs APLS Comparison

HNI vs APLS Comparison

Compare HNI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNI
  • APLS
  • Stock Information
  • Founded
  • HNI 1944
  • APLS 2009
  • Country
  • HNI United States
  • APLS United States
  • Employees
  • HNI N/A
  • APLS N/A
  • Industry
  • HNI Office Equipment/Supplies/Services
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNI Consumer Discretionary
  • APLS Health Care
  • Exchange
  • HNI Nasdaq
  • APLS Nasdaq
  • Market Cap
  • HNI 2.0B
  • APLS 2.2B
  • IPO Year
  • HNI N/A
  • APLS 2017
  • Fundamental
  • Price
  • HNI $52.10
  • APLS $18.25
  • Analyst Decision
  • HNI Strong Buy
  • APLS Buy
  • Analyst Count
  • HNI 2
  • APLS 19
  • Target Price
  • HNI $66.50
  • APLS $37.39
  • AVG Volume (30 Days)
  • HNI 313.9K
  • APLS 1.9M
  • Earning Date
  • HNI 07-24-2025
  • APLS 07-31-2025
  • Dividend Yield
  • HNI 2.63%
  • APLS N/A
  • EPS Growth
  • HNI 100.29
  • APLS N/A
  • EPS
  • HNI 2.80
  • APLS N/A
  • Revenue
  • HNI $2,538,200,000.00
  • APLS $775,839,000.00
  • Revenue This Year
  • HNI $4.50
  • APLS $1.01
  • Revenue Next Year
  • HNI $3.48
  • APLS $22.14
  • P/E Ratio
  • HNI $18.46
  • APLS N/A
  • Revenue Growth
  • HNI N/A
  • APLS 48.04
  • 52 Week Low
  • HNI $39.76
  • APLS $16.10
  • 52 Week High
  • HNI $58.42
  • APLS $42.47
  • Technical
  • Relative Strength Index (RSI)
  • HNI 71.11
  • APLS 48.67
  • Support Level
  • HNI $48.83
  • APLS $17.15
  • Resistance Level
  • HNI $51.93
  • APLS $18.60
  • Average True Range (ATR)
  • HNI 1.13
  • APLS 0.70
  • MACD
  • HNI 0.39
  • APLS -0.04
  • Stochastic Oscillator
  • HNI 97.34
  • APLS 45.25

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: